Mycoplasma infection (respiratory)

Mycoplasma infection affecting the respiratory system in cats is caused by bacteria belonging to the genus Mycoplasma, which are among the smallest free-living organisms capable of causing disease. These unique bacteria lack a cell wall, distinguishing them from most other bacterial pathogens and influencing treatment approach. Respiratory mycoplasma infection in cats commonly involves the upper respiratory tract, though lower respiratory involvement including pneumonia can also occur. The infection is particularly prevalent in multi-cat environments such as shelters, catteries, and households with multiple feline residents.

Mycoplasma species infect cats through direct contact with infected individuals or contaminated respiratory secretions. The bacteria colonize the mucous membranes of the respiratory tract, where they attach to epithelial cells and cause inflammation and tissue damage. Several Mycoplasma species can infect cats, with Mycoplasma felis being the most commonly implicated in respiratory disease. These organisms may act as primary pathogens or as secondary invaders following viral upper respiratory infections, complicating the clinical picture and potentially worsening disease severity.

The impact of respiratory mycoplasma infection ranges from mild upper respiratory signs to more serious lower respiratory disease. Common manifestations include sneezing, nasal discharge, conjunctivitis, and coughing. In some cats, particularly those with compromised immune systems or concurrent infections, mycoplasma can contribute to pneumonia with more severe respiratory compromise. Chronic or recurrent respiratory problems may develop in some affected individuals, especially if the infection is not adequately treated or if underlying conditions persist.

Respiratory mycoplasma infections in cats are typically treatable with appropriate antibiotic therapy. However, the lack of a cell wall in these organisms renders certain commonly used antibiotics ineffective, requiring selection of appropriate antimicrobial agents that target alternative bacterial structures. Early recognition and treatment generally leads to favorable outcomes, though cats in high-risk environments may experience reinfection. Understanding this condition helps cat owners recognize signs requiring veterinary attention and implement appropriate preventive measures to protect their feline companions.

Respiratory mycoplasma infection in cats results from colonization and infection of the respiratory mucosa by bacteria of the genus Mycoplasma. These organisms represent some of the smallest and simplest self-replicating bacteria, lacking the rigid cell wall structure found in most other bacteria. This unique biological characteristic has important implications for both disease mechanism and treatment, as cell wall-targeting antibiotics are ineffective against these pathogens. Several Mycoplasma species have been identified in cats, with different species associated with different clinical syndromes.

Mycoplasma felis is the primary species implicated in feline respiratory infections, though other species including Mycoplasma gateae and Mycoplasma arginini may also be involved. These organisms are adapted to survive on the mucous membranes of the respiratory tract, where they attach to epithelial cells using specialized adhesion proteins. Once attached, mycoplasmas cause cellular damage through multiple mechanisms including nutrient competition, production of hydrogen peroxide and ammonia, and triggering of inflammatory responses. The resulting tissue damage and inflammation produce the clinical signs of respiratory infection.

Transmission of respiratory mycoplasma occurs through direct contact between cats or through exposure to respiratory secretions from infected individuals. Sneezing and coughing generate aerosol droplets containing the organisms, which can infect susceptible cats in close proximity. Fomite transmission through contaminated objects such as food bowls, bedding, and human hands is also possible, though mycoplasmas survive poorly in the environment compared to many other pathogens. High-density living situations dramatically increase transmission opportunities, explaining the high prevalence in shelters and multi-cat households.

Several risk factors predispose cats to respiratory mycoplasma infection. Living in crowded conditions with many cats creates abundant transmission opportunities. Young kittens and older cats with less robust immune function face increased susceptibility. Concurrent viral infections, particularly feline herpesvirus and feline calicivirus, damage respiratory mucosa and facilitate mycoplasma colonization. Stress from any source, including environmental changes, overcrowding, or concurrent illness, suppresses immune function and increases infection risk. Cats with feline immunodeficiency virus or feline leukemia virus infections have compromised immunity that increases susceptibility to all infectious diseases including mycoplasma.

The mechanism of mycoplasma-induced disease involves both direct tissue damage and inflammatory responses. After attachment to respiratory epithelial cells, the organisms cause cellular dysfunction and death through competition for nutrients, particularly arginine and other amino acids. Metabolic byproducts including hydrogen peroxide, ammonia, and nucleases directly damage host cells. The host immune response, while attempting to clear infection, contributes to tissue inflammation and clinical signs. Chronic infection may develop as mycoplasmas evade immune clearance through antigenic variation and immunomodulatory effects. The resulting chronic inflammation can lead to ongoing respiratory problems even after active infection is controlled.

Respiratory mycoplasma infection in cats produces a range of clinical signs primarily affecting the upper and occasionally lower respiratory tract. The severity and specific manifestations vary depending on the individual cat's immune status, presence of concurrent infections, and the specific mycoplasma species involved. Recognizing these signs enables cat owners to seek appropriate veterinary care and prevent progression to more serious disease.

Early warning signs of respiratory mycoplasma infection often begin subtly before progressing to more obvious symptoms. Owners may notice slightly increased sneezing frequency that gradually becomes more persistent. Mild eye discharge, initially clear and watery, may appear. Subtle changes in energy levels or slight appetite reduction sometimes precede more overt respiratory signs. Some cats develop mild nasal stuffiness evidenced by slightly noisy breathing, particularly during rest. These early signs are easily attributed to minor irritations or dismissed entirely, allowing infection to establish before treatment is sought.

As infection progresses, common symptoms become more apparent and concerning. Sneezing becomes frequent and may occur in pronounced bouts. Nasal discharge develops, typically starting as clear and watery but potentially becoming thicker and discolored as secondary bacterial involvement occurs. Conjunctivitis causes red, swollen, watery eyes that may develop mucopurulent discharge. Coughing may develop, ranging from occasional dry coughs to more persistent productive coughing. Fever is common during active infection, contributing to lethargy and decreased appetite. Some cats develop voice changes or become hoarse due to laryngeal inflammation.

Behavioral changes accompanying respiratory mycoplasma infection reflect both respiratory discomfort and systemic illness. Affected cats typically become less active, preferring rest to normal play and exploration. Appetite often decreases, partly due to nasal congestion impairing smell and partly due to general malaise. Cats may sleep more than usual and show less interest in interacting with family members or other pets. Grooming behaviors may decrease as cats focus energy on fighting infection. Some cats become irritable or withdrawn, seeking isolated locations rather than usual social spots. Breathing with mouth open may occur if nasal passages become significantly congested.

Physical signs observable by attentive owners provide valuable diagnostic information. Ocular discharge may be visible as tear staining or crusting around the eyes. Nasal discharge may cause staining around the nostrils and frequent face-pawing. Respiratory effort may be visibly increased, with faster breathing or more pronounced chest or abdominal movement. Cats with significant lower respiratory involvement may exhibit labored breathing, extended neck posture, or open-mouth breathing. Weight loss develops with prolonged decreased appetite. General unkempt appearance reflects reduced grooming and overall poor condition.

Symptom progression varies depending on treatment timing and individual factors. Without treatment, mild upper respiratory signs may persist chronically or wax and wane over time. Secondary bacterial infections can develop, worsening nasal and ocular discharge character. Lower respiratory involvement with pneumonia produces more serious signs including labored breathing, pronounced lethargy, high fever, and significant appetite loss. Chronic infection may lead to ongoing nasal congestion, recurrent conjunctivitis, or persistent cough. Signs requiring emergency veterinary attention include severe breathing difficulty, open-mouth breathing, blue-tinged gums indicating oxygen deprivation, complete refusal to eat for more than 24 hours, or profound weakness. These signs indicate serious compromise requiring immediate intervention.

Diagnosing respiratory mycoplasma infection in cats requires clinical assessment combined with specific laboratory testing when definitive diagnosis is needed. Mycoplasma infection often occurs as part of the feline upper respiratory infection complex, making differentiation from other pathogens clinically important for appropriate treatment selection. The veterinary evaluation establishes the extent of respiratory involvement and rules out other conditions requiring different therapeutic approaches.

The initial veterinary examination comprehensively evaluates the respiratory system and overall health status. Physical assessment includes listening to lung sounds for abnormalities such as crackles or wheezes, evaluating nasal discharge character, examining the eyes for conjunctivitis, and checking lymph nodes for enlargement. Temperature measurement detects fever common with active infection. Thorough history-taking covers symptom duration and progression, other cats in the household and their health status, recent environmental changes or stressors, and any previous respiratory problems. This information helps assess mycoplasma likelihood and guides diagnostic planning.

Basic diagnostic testing establishes overall health status and may reveal infection-related changes. Complete blood count sometimes shows elevated white blood cell counts indicating infection, though normal counts do not rule out mycoplasma. Serum chemistry panels evaluate organ function and overall metabolic status. Thoracic radiographs are indicated for cats with suspected lower respiratory involvement, revealing patterns suggestive of pneumonia such as increased lung opacity or bronchial patterns. These baseline tests help characterize disease severity and identify cats needing more aggressive treatment.

Specific diagnosis of mycoplasma infection utilizes specialized laboratory testing. Polymerase chain reaction testing of respiratory swabs or lavage samples provides sensitive and specific detection of mycoplasma DNA, allowing rapid confirmation and sometimes species identification. Mycoplasma culture can be performed but requires specialized media and growth conditions, with relatively slow turnaround times. Cytological examination of conjunctival or respiratory samples may suggest mycoplasma involvement when characteristic organisms are visible, though this is not highly sensitive. Serological testing detecting antibodies has limited diagnostic utility due to cross-reactivity and inability to distinguish current from past infection.

Differential diagnosis for cats presenting with respiratory signs includes the various components of the feline upper respiratory infection complex. Feline herpesvirus and feline calicivirus are common causes of upper respiratory disease with overlapping presentations. Chlamydophila felis primarily causes conjunctivitis but may contribute to respiratory signs. Bordetella bronchiseptica causes respiratory infection particularly in shelter environments. Fungal infections, foreign bodies, and neoplasia enter the differential for cats with chronic or atypical presentations. Concurrent infection with multiple pathogens is common, as viral damage to respiratory mucosa predisposes to secondary bacterial invasion. Accurate identification of involved pathogens guides appropriate antimicrobial selection and helps predict prognosis.

Treatment of respiratory mycoplasma infection in cats requires appropriate antimicrobial selection that accounts for the unique biology of these organisms, combined with supportive care to address symptoms and promote recovery. The lack of a cell wall in mycoplasmas makes standard antibiotics targeting cell wall synthesis, such as penicillins and cephalosporins, ineffective. Treatment planning considers disease severity, concurrent infections, and individual patient factors to achieve optimal outcomes.

Initial treatment approach varies with disease severity. Cats with mild upper respiratory signs may be managed on an outpatient basis with oral medications and home supportive care. Those with more severe illness, including significant pneumonia, high fever, dehydration, or respiratory distress, benefit from hospitalization and more intensive therapy. Oxygen supplementation helps cats with compromised breathing. Intravenous fluid therapy corrects dehydration and supports overall perfusion. Nebulization with saline can help loosen respiratory secretions and improve comfort. Nutritional support through assisted feeding may be necessary for cats refusing food.

Antimicrobial therapy targets mycoplasma effectively using drugs that inhibit protein synthesis or DNA replication rather than cell wall synthesis. Doxycycline is commonly the first-choice antibiotic for feline respiratory mycoplasma, with typical treatment duration of two to three weeks. Fluoroquinolones such as marbofloxacin or pradofloxacin provide alternative options, though doxycycline is generally preferred when appropriate. Azithromycin and other macrolide antibiotics also have activity against mycoplasma. When concurrent bacterial infections are suspected, broader-spectrum coverage may be appropriate. Treatment duration should be adequate to prevent relapse, as premature discontinuation may lead to recurrence.

Surgical intervention is not typically part of respiratory mycoplasma treatment, as this is primarily a medical condition. However, cats with concurrent conditions requiring surgical attention, such as severe dental disease contributing to respiratory problems, may benefit from appropriate procedures once stabilized. Sample collection for diagnostic testing through techniques like transtracheal wash or bronchoalveolar lavage may be performed in cases requiring definitive diagnosis, though these are diagnostic rather than therapeutic procedures.

Supportive care addresses symptoms and promotes recovery alongside antimicrobial therapy. Steam therapy or nebulization helps loosen nasal congestion and respiratory secretions. Gentle cleaning of nasal and ocular discharge maintains comfort and prevents crusting. Encouraging fluid intake through water fountains or flavored broths supports hydration. Highly palatable foods with strong aromas help stimulate appetite in cats with diminished smell due to nasal congestion. Environmental modification including humidity control and stress reduction supports recovery. Anti-nausea medications may help cats with reduced appetite.

Alternative and complementary approaches may support conventional treatment. L-lysine supplementation, while primarily used for feline herpesvirus, may provide general immune support in cats with concurrent viral infections. Probiotics help maintain healthy gastrointestinal flora during antibiotic treatment. Nutritional supplements supporting immune function may be beneficial. Environmental enrichment and stress reduction support overall wellbeing and immune function. These approaches complement but do not replace appropriate antimicrobial therapy.

Treatment decisions consider multiple factors affecting the individual case. Disease severity guides treatment intensity and setting. Concurrent infections may require additional antimicrobials or modified treatment protocols. Chronic or recurrent cases may need extended treatment courses or environmental investigation to identify persistent infection sources. In multi-cat households or catteries, treatment of affected individuals should be accompanied by evaluation of apparently healthy cats for subclinical infection. Financial considerations may influence treatment options, though basic antimicrobial therapy is generally affordable. Owner ability to administer medications reliably affects treatment selection and success.

Recovery from respiratory mycoplasma infection in cats typically proceeds smoothly with appropriate antibiotic therapy, though the timeline varies depending on disease severity and individual patient factors. Understanding the expected recovery course helps owners provide appropriate support and recognize potential complications requiring veterinary attention. Most cats with uncomplicated respiratory mycoplasma infection recover fully without long-term consequences.

The recovery timeline for respiratory mycoplasma generally spans two to four weeks, with clinical improvement often visible within the first week of appropriate antibiotic therapy. Initial improvement typically includes reduced sneezing frequency, clearing of eye discharge, and improved appetite and energy levels. Nasal discharge may initially appear worse as treatment helps mobilize accumulated secretions, then gradually resolves. Full resolution of all symptoms may take two to three weeks. The antibiotic course should be completed as prescribed even after symptoms resolve to ensure complete eradication and prevent relapse.

Post-treatment care focuses on monitoring for complete resolution and preventing reinfection. Owners should continue observing their cat for any recurrence of respiratory signs after treatment completion. Maintaining good nutrition supports immune function and recovery. Reducing environmental stressors helps prevent immune suppression that could lead to recurrence. Cats recovering from respiratory infection should be kept separate from newly introduced cats that could transmit different pathogens. Follow-up veterinary visits may be recommended for cats with severe initial disease or slow recovery to ensure complete resolution.

Prognostic factors influencing recovery include the cat's age and overall health status, severity of illness at diagnosis, presence of concurrent infections, and promptness of appropriate treatment. Young, previously healthy cats typically recover completely within expected timeframes. Cats with underlying immunosuppression from retroviral infections or other causes may experience prolonged or incomplete recovery. Severe pneumonia carries more guarded prognosis than mild upper respiratory infection. Chronic carriers of mycoplasma may develop recurrent episodes triggered by stress or immune suppression.

Long-term outlook for most cats recovering from respiratory mycoplasma infection is excellent. Complete resolution without lasting effects is the expected outcome for uncomplicated cases. Some cats may become chronic carriers, harboring organisms in the respiratory tract without active disease but potentially serving as infection sources for other cats. Cats with repeated infections or chronic respiratory problems following mycoplasma may develop chronic rhinosinusitis or other persistent issues. In multi-cat households, addressing all infected individuals and implementing preventive measures helps prevent ongoing transmission cycles. Overall, respiratory mycoplasma represents a manageable infection with favorable outcomes when appropriately treated.

Preventing respiratory mycoplasma infection in cats involves reducing exposure to the organism, maintaining robust immune function, and implementing appropriate management in multi-cat environments. While complete prevention is challenging, particularly in high-risk settings, practical measures can significantly reduce infection incidence and severity. Understanding transmission dynamics enables implementation of effective preventive strategies.

Primary prevention focuses on limiting exposure to infected cats and contaminated materials. Quarantining new cats before introducing them to a household allows detection and treatment of infections before transmission to resident cats. Ideally, new arrivals should be isolated for two to three weeks with separate caregivers and equipment. Avoiding contact with cats of unknown health status at shows, boarding facilities, or other venues reduces exposure risk. In shelter environments, flow-through housing systems that minimize co-mingling and dedicated staff assignments for different areas help control transmission.

Environmental management reduces transmission in multi-cat settings. Regular cleaning and disinfection of shared surfaces, food bowls, water dishes, and litter boxes limits fomite transmission. Although mycoplasmas survive poorly outside hosts, contaminated materials can serve as short-term transmission vehicles. Adequate ventilation helps reduce aerosol pathogen concentrations. Maintaining appropriate population density prevents overcrowding stress that suppresses immunity and increases transmission opportunities. Separation of cats showing respiratory signs from apparently healthy individuals limits spread during outbreaks.

Dietary and immune-supporting measures enhance resistance to infection. Feeding nutritionally complete, high-quality diets supports overall immune function. Maintaining healthy body condition without obesity or underweight optimizes immune capability. Reducing stress through stable environments, adequate resources, and appropriate social groupings supports immunity. Prompt treatment of underlying conditions that could compromise immune function, including dental disease and parasitic infections, maintains health. While no specific supplements have proven effectiveness for mycoplasma prevention, general immune-supporting nutrition is beneficial.

Regular veterinary care supports prevention through health maintenance and early problem detection. Routine examinations allow identification of developing respiratory problems before they become severe. Vaccination against feline herpesvirus and calicivirus reduces susceptibility to these viral infections that often predispose to secondary mycoplasma. Testing for feline immunodeficiency virus and feline leukemia virus identifies cats at increased risk who may benefit from enhanced monitoring. Prompt attention to respiratory symptoms facilitates early treatment that limits severity and reduces transmission to other cats. In catteries and breeding facilities, ongoing health monitoring and protocols for managing respiratory disease help maintain population health.

Managing a cat with respiratory mycoplasma infection, whether during acute illness or chronic carriage, involves attention to daily care needs, environmental optimization, and ongoing health monitoring. Most cats with acute infections recover fully and require no special long-term management, but understanding supportive care during illness and recognizing signs requiring attention ensures optimal outcomes. For cats with chronic or recurrent issues, more extensive ongoing management may be necessary.

Daily management during acute infection focuses on supporting recovery while administering prescribed medications. Consistent antibiotic administration at prescribed intervals is essential for treatment success. Gentle cleaning of nasal and ocular discharge with warm, damp cotton balls maintains comfort and prevents crusting that can worsen congestion. Encouraging food intake through warming food to enhance aroma, offering favorite treats, and hand-feeding if necessary ensures adequate nutrition during recovery. Providing fresh water in multiple locations promotes hydration. Maintaining normal routines as much as possible reduces stress that can impair immune function.

Home environment modifications support comfort during illness and may benefit chronic cases. Increasing environmental humidity through humidifiers or allowing cats access to steamy bathrooms after showers helps loosen respiratory secretions. Maintaining clean air by avoiding smoking, strong perfumes, dusty litter, and other respiratory irritants reduces additional airway stress. Providing warm, comfortable resting areas supports a sick cat's need for increased sleep. In multi-cat households, temporarily separating ill cats from healthy housemates prevents transmission while allowing peaceful recovery. Easy access to food, water, and litter boxes reduces physical demands on recovering cats.

Quality of life considerations ensure cats with respiratory issues maintain satisfactory wellbeing. Most cats with acute mycoplasma infections remain comfortable with appropriate supportive care and continue to enjoy normal activities as they recover. Chronic cases may require ongoing management adjustments but generally maintain good quality of life. Monitoring for signs of respiratory distress, significant appetite loss, or marked behavioral changes allows prompt intervention when needed. Providing enrichment appropriate to the cat's energy level maintains mental stimulation without overtaxing recovering patients. Most cats return to normal activity levels and behavior following recovery.

Ongoing monitoring detects problems early and guides management adjustments. During acute illness, daily assessment of appetite, activity, and respiratory signs tracks recovery progress. After treatment completion, continued observation for several weeks detects potential relapse. Cats with chronic respiratory issues benefit from regular veterinary check-ups to monitor for disease progression. Weight monitoring helps detect inadequate nutrition that may indicate ongoing problems. Warning signs requiring veterinary attention include worsening respiratory signs, complete appetite loss, significant lethargy, or fever. Maintaining communication with the veterinary team ensures appropriate responses to changing conditions.

Caregiver support helps owners manage the demands of caring for sick cats. Understanding that respiratory infections typically resolve with appropriate treatment provides reassurance during the illness period. Connecting with veterinary staff for guidance on supportive care techniques ensures effective home management. For cats with chronic issues, developing sustainable care routines prevents caregiver burnout. Recognizing that providing attentive nursing care significantly supports recovery encourages continued effort. Most respiratory mycoplasma infections resolve completely, allowing cats and owners to return to normal life within a few weeks.

Respiratory mycoplasma infection in cats does not demonstrate significant breed predisposition, as susceptibility relates primarily to environmental exposure, age, and immune status rather than genetic factors. All cat breeds and mixed heritage cats can be affected when exposed to the organism under conditions favoring transmission. However, certain living situations and individual characteristics influence infection risk regardless of breed.

Cats living in high-density environments face elevated risk for respiratory mycoplasma regardless of breed background. Shelter cats experience high transmission rates due to crowding, stress, and exposure to many individuals of unknown health status. Cats in breeding facilities or catteries similarly face increased risk from close contact with multiple animals. Multi-cat households, particularly those with more than four or five cats, have higher infection pressure than single-cat homes. Rescue cats and strays often have exposure histories that include high-risk environments. These environmental factors far outweigh any theoretical breed susceptibility in determining infection likelihood.

Brachycephalic breeds, including Persians, Himalayans, and Exotic Shorthairs, may experience more pronounced symptoms from respiratory infections due to their conformationally narrowed airways. While not specifically more susceptible to mycoplasma infection, these breeds may struggle more with nasal congestion and respiratory secretions. Their predisposition to eye problems may also lead to more severe conjunctivitis manifestations. These breeds benefit from particularly attentive supportive care during respiratory infections. Similarly, breeds with known immunological differences, though none are specifically linked to mycoplasma susceptibility, might theoretically have altered infection responses.

Age represents a more significant risk factor than breed for respiratory mycoplasma susceptibility. Kittens with immature immune systems face higher infection rates and may experience more severe disease. Older cats with age-related immune decline similarly show increased susceptibility. Cats of any breed with underlying health conditions affecting immunity, including feline immunodeficiency virus, feline leukemia virus, or diabetes, face elevated risk. Screening recommendations focus on these risk factors rather than breed. All new cats entering multi-cat environments should be quarantined and evaluated for respiratory health regardless of breed. Cats with chronic or recurrent respiratory problems warrant investigation for underlying mycoplasma and other pathogens irrespective of breed background.

Understanding conditions related to respiratory mycoplasma infection provides important context for diagnosis, treatment, and management. Related conditions include other components of the feline upper respiratory infection complex that commonly occur concurrently, diseases requiring differentiation, and potential complications of mycoplasma infection.

Respiratory mycoplasma frequently occurs alongside other pathogens as part of the feline upper respiratory infection complex. Feline herpesvirus type 1 is a leading cause of upper respiratory infection that often co-infects with mycoplasma. Viral damage to respiratory epithelium facilitates mycoplasma attachment and invasion, making concurrent infection common. Feline calicivirus similarly predisposes to secondary bacterial infection. Chlamydophila felis causes conjunctivitis and mild respiratory signs that may overlap with mycoplasma presentation. Bordetella bronchiseptica causes respiratory infection particularly in high-density environments. Managing cats with respiratory infections often requires addressing multiple pathogens simultaneously.

Several conditions produce respiratory signs requiring differentiation from mycoplasma infection. Feline asthma causes coughing and respiratory distress but responds to different treatments. Cardiac disease can cause respiratory signs including coughing and labored breathing. Nasopharyngeal polyps cause upper respiratory obstruction and discharge. Respiratory neoplasia, including nasal tumors and pulmonary lymphoma, produces chronic respiratory signs. Fungal infections such as cryptococcosis can affect the respiratory tract. Foreign body aspiration causes acute respiratory signs. Accurate differentiation through appropriate diagnostic testing guides correct treatment selection.

Complications of respiratory mycoplasma infection extend beyond acute respiratory illness in some cases. Chronic rhinosinusitis may develop following acute infection, causing ongoing nasal discharge and congestion. Chronic carrier states allow cats to harbor organisms without active disease while potentially transmitting to others. Secondary bacterial infections with opportunistic pathogens may complicate recovery. Spread to other body systems is uncommon with respiratory mycoplasma but other mycoplasma species can cause anemia and arthritis in cats. Recurrent infections may occur, particularly in cats with ongoing exposure in multi-cat environments or underlying immune compromise. Recognition of these potential complications informs monitoring strategies and helps owners understand the importance of complete treatment and follow-up care.